Apixaban as Treatment of Venous Thrombosis in Patients With Cancer: The CAP Study

PHASE4CompletedINTERVENTIONAL

Enrollment

300

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

May 31, 2018

Study Completion Date

May 31, 2018

Conditions

NeoplasmsVenous Thrombosis

Interventions

DRUG

Apixaban

Trial Locations (9)

Vestre Viken - Bærum sykehus, Gjettum

Department of Hematology, Akershus University Hospital, Lørenskog

Haukeland University Hospital, Bergen

Vestre Viken- Drammen Hospital, Drammen

Oslo University Hospital, Oslo

Østfold Hospital Kalnes, Sarpsborg

Stavanger University Hospital, Stavanger

St. Olavs Hospital, Trondheim

Volda Hospital, Volda

All Listed Sponsors

lead

University Hospital, Akershus

OTHER

NCT02581176 - Apixaban as Treatment of Venous Thrombosis in Patients With Cancer: The CAP Study | Biotech Hunter | Biotech Hunter